Literature DB >> 35273439

Multivessel versus Culprit-Only Revascularization Strategies in Cardiac Arrest Survivors.

Wei-Ting Chen1, Min-Shan Tsai1, Chien-Hua Huang1, Chih-Wei Sung2, Po-Ya Chuang3, Chih-Hung Wang1, Yen-Wen Wu4, Wei-Tien Chang1, Wen-Jone Chen1,5.   

Abstract

Background: Whether multivessel revascularization or culprit-only revascularization is more beneficial in cardiac arrest survivors with multivessel coronary artery disease remains unclear. We aimed to retrospectively evaluate whether multivessel or culprit-only revascularization following cardiac arrest was associated with a reduced incidence of in-hospital mortality.
Methods: A total of 273 adult nontraumatic cardiac arrest survivors (aged ≥ 18 years) who underwent emergent coronary angiography (CAG) within 24 h following cardiac arrest were retrospectively recruited from three hospitals. Patients without definite coronary artery stenosis (n = 72), one-vessel stenosis (n = 74), or failed percutaneous coronary intervention (PCI; n = 37) were excluded. A total of 90 patients were enrolled for the final analysis and classified into multivessel (revascularization of more than one major vessel during the index CAG; n = 45) and culprit-only (revascularization of the infarct-related artery alone; n = 45) groups.
Results: Twenty-five patients (55.6%) in the culprit-only group and 17 patients (37.8%) in the multivessel group failed to survive to discharge [adjusted hazard ratio (HR) = 0.47, 95% confidence interval (CI) = 0.24-0.95, p = 0.035]. The benefit of multivessel revascularization on survival was obvious among those with a prolonged cardiopulmonary resuscitation duration (> 10 min) (47.82% vs. 76.92%, adjusted HR = 0.27, 95% CI = 0.08-0.93, p = 0.03). No difference in neurological outcomes (favorable = cerebral performance category scores 1-2; poor = 3-5) between groups was observed (60.0% vs. 55.6%, adjusted OR = 1.22, 95% CI = 0.35-4.26, p = 0.753). Conclusions: Compared with culprit-only revascularization, multivessel revascularization was associated with lower in-hospital mortality among cardiac arrest survivors with multivessel lesions. Owing to the retrospective design and small sample size, the current study should be interpreted as observational and exploratory.

Entities:  

Keywords:  Cardiac arrest; Coronary angiography; Multivessel coronary artery disease; Percutaneous coronary intervention; Survival

Year:  2022        PMID: 35273439      PMCID: PMC8888317          DOI: 10.6515/ACS.202203_38(2).20211107A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  33 in total

1.  2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Authors:  Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Henry H Ting; Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Ralph G Brindis; Donald E Casey; Mina K Chung; James A de Lemos; Deborah B Diercks; James C Fang; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao
Journal:  Circulation       Date:  2015-10-21       Impact factor: 29.690

2.  Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease.

Authors:  Lisette Okkels Jensen; Per Thayssen; Dóra Körmendiné Farkas; Mikkel Hougaard; Christian Juhl Terkelsen; Hans-Henrik Tilsted; Michael Maeng; Anders Junker; Jens Flensted Lassen; Erzsébet Horváth-Puhó; Henrik Toft Sørensen; Leif Thuesen
Journal:  EuroIntervention       Date:  2012-08       Impact factor: 6.534

3.  Complete Revascularization with Multivessel PCI for Myocardial Infarction. Reply.

Authors:  Shamir R Mehta; David A Wood; John A Cairns
Journal:  N Engl J Med       Date:  2020-04-16       Impact factor: 91.245

4.  Stenosis and revascularization of the coronary artery are associated with outcomes in presumed cardiogenic arrest survivors: A multi-center retrospective cohort study.

Authors:  Min-Shan Tsai; Chih-Wei Sung; Wen-Jone Chen; Po-Ya Chuang; Chih-Hung Wang; Yen-Wen Wu; Wei-Tien Chang; Wei-Ting Chen; Chien-Hua Huang
Journal:  Resuscitation       Date:  2019-02-15       Impact factor: 5.262

5.  Culprit Vessel Only Versus Multivessel Percutaneous Coronary Intervention in Acute Myocardial Infarction with Cardiogenic Shock: A Systematic Review and Meta-Analysis.

Authors:  Muhammad Faisal Khalid; Abdul Ahad Khan; Furqan Khattak; Muhammad Talha Ayub; Jayant Bagai; Debabrata Mukherjee; Thomas Helton; Mauricio G Cohen; Subhash Banerjee; Timir K Paul
Journal:  Cardiovasc Revasc Med       Date:  2018-12-21

6.  Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial.

Authors:  Holger Thiele; Steffen Desch; Jan J Piek; Janina Stepinska; Keith Oldroyd; Pranas Serpytis; Gilles Montalescot; Marko Noc; Kurt Huber; Georg Fuernau; Suzanne de Waha; Roza Meyer-Saraei; Steffen Schneider; Stephan Windecker; Stefano Savonitto; Andrew Briggs; Patrizia Torremante; Christiaan Vrints; Gerhard Schuler; Uta Ceglarek; Joachim Thiery; Uwe Zeymer
Journal:  Am Heart J       Date:  2015-12-01       Impact factor: 4.749

7.  Multiple complex coronary plaques in patients with acute myocardial infarction.

Authors:  J A Goldstein; D Demetriou; C L Grines; M Pica; M Shoukfeh; W W O'Neill
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

8.  Metaanalysis of Multivessel vs Culprit Artery Only Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction.

Authors:  Daniel C Garcia; Alexandre M Benjo; Christopher J White; Rhanderson N Cardoso; Francisco Y B Macedo; Alan H Schob; Georges E El-Hayek; Girish N Nadkarni; Emad F Aziz; Rajan A G Patel
Journal:  Ochsner J       Date:  2019

9.  Randomized trial of preventive angioplasty in myocardial infarction.

Authors:  David S Wald; Joan K Morris; Nicholas J Wald; Alexander J Chase; Richard J Edwards; Liam O Hughes; Colin Berry; Keith G Oldroyd
Journal:  N Engl J Med       Date:  2013-09-01       Impact factor: 91.245

10.  Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.

Authors:  Anthony H Gershlick; Jamal Nasir Khan; Damian J Kelly; John P Greenwood; Thiagarajah Sasikaran; Nick Curzen; Daniel J Blackman; Miles Dalby; Kathryn L Fairbrother; Winston Banya; Duolao Wang; Marcus Flather; Simon L Hetherington; Andrew D Kelion; Suneel Talwar; Mark Gunning; Roger Hall; Howard Swanton; Gerry P McCann
Journal:  J Am Coll Cardiol       Date:  2015-03-17       Impact factor: 24.094

View more
  1 in total

1.  Complete Revascularization and One-Year Survival with Good Neurological Outcome in Patients Resuscitated from an Out-of-Hospital Cardiac Arrest.

Authors:  Vilma Kajana; Enrico Baldi; Francesca Romana Gentile; Sara Compagnoni; Federico Quilico; Luca Vicini Scajola; Alessandra Repetto; Alessandro Mandurino-Mirizzi; Marco Ferlini; Barbara Marinoni; Maurizio Ferrario Ormezzano; Roberto Primi; Sara Bendotti; Alessia Currao; Simone Savastano
Journal:  J Clin Med       Date:  2022-08-29       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.